4//SEC Filing
Norstrud Andrew James 4
Accession 0001181431-09-043210
CIK 0001360479other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 6:15 PM ET
Size
7.1 KB
Accession
0001181431-09-043210
Insider Transaction Report
Form 4
Norstrud Andrew James
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2009-07-27$0.06/sh+1,000,000$59,000→ 1,000,000 total - Award
Common Stock Option
2009-09-04$0.04/sh+900,000$36,000→ 1,300,000 totalExercise: $0.01From: 2009-09-04Exp: 2019-09-04→ Common Stock (900,000 underlying)
Footnotes (1)
- [F1]Granted for the relief of compensation owed
Documents
Issuer
Stem Cell Therapy International, Inc.
CIK 0001360479
Entity typeother
Related Parties
1- filerCIK 0001311402
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 6:15 PM ET
- Size
- 7.1 KB